AS Latvijas Juras medicinas centrs (ORSE:LJM1R) Moat Score: 0/10 (As of Jul. 12, 2026)


ORSE:LJM1R AS Latvijas Juras medicinas centrs ORSE:LJM1R
59 GF Score
Price €7.80
GF Value €7.78
! 3 Warning Signs
View Full Analysis

What is AS Latvijas Juras medicinas centrs Moat Score?

AS Latvijas Juras medicinas centrs has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

AS Latvijas Juras medicinas centrs has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes AS Latvijas Juras medicinas centrs might have No Moat - No discernible moat.

AS Latvijas Juras medicinas centrs  (ORSE:LJM1R) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

AS Latvijas Juras medicinas centrs Moat Score Related Terms

ORSE:LJM1R
59GF Score
AS Latvijas Juras medicinas centrs ORSE:LJM1R
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is AS Latvijas Juras medicinas centrs (ORSE:LJM1R) Overvalued in 2026?

Based on GuruFocus' analysis, AS Latvijas Juras medicinas centrs stock appears to be overvalued. The current stock price of €7.80 is trading 0.3% above its estimated GF Value™ of €7.78.

Key valuation signals for ORSE:LJM1R:

  • Moat Score: 0
  • GF Value™: €7.78 vs. price of €7.80 (0.3% above fair value)
  • GF Score™: 59/100 with 3 warning signs

No single metric tells the full story. See the ORSE:LJM1R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

AS Latvijas Juras medicinas centrs Business Description

Address Patversmes iela 23, Riga, LVA, LV-1005
AS Latvijas Juras medicinas centrs is a private certified medical institution in Latvia providing outpatient and inpatient healthcare services through qualified staff and modern equipment. Its core activities include hospital services, orthopaedic retail, medical and dental practice, human health and residential care, social work activities, and physical well-being services. It operates the Women's Health Clinic, offering gynecological consultations, pregnancy care, diagnostics, postpartum services, gynecological care for girls, and surgery. The centre also provides vaccination, rehabilitation, a Multiple Sclerosis Center, medical commission, home visits, laboratory services, physical medicine and massage, therapeutic procedures, medical treatment, and anesthesia and intensive care.
59GF Score

Get the complete analysis for ORSE:LJM1R

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€7.80
Price
€7.78
GF Value